首页> 中文期刊>国际医药卫生导报 >急性心肌梗死院前溶栓与院内溶栓的临床分析

急性心肌梗死院前溶栓与院内溶栓的临床分析

摘要

目的 探讨院前溶栓治疗急性心肌梗死的临床效果.方法 回顾分析本院收治的AMI患者46例,其中20例于我院急诊科进行院前溶栓治疗,26例进行院内溶栓,并将两者对比分析.结果 就诊至溶栓治疗时间,院前溶栓组为(15.11±10.25)min,院内溶仑组为(45.51±15.29)min.血管再通率院前组为70%,院内组为65.38%.心脏事件发生率院前组为10%,院内组为23.07%.两组相比差异有显著性(P<0.05).结论 对急性心肌梗死患者进行院前溶栓治疗能缩短发病至开始溶栓的时间,提高冠脉再通率,降低心脏事件发生率,是必要、可行和安全的.%Objective To explore the efficacy of prehospital thrombolytic therapy in patients with acute myocardial infarction (AMI). Methods 46 patients who had received thrombolytic therapy were enrolled in this retrospective analysis, 20 of whom received prehospital and the rest 26 received in-hospital thrombolytic treatment (control group). Results The duration from diagnosis to thrombolytic treatment was shorter in the study group than in the control group (15.11 ± 10.25 vs. 45.51 ± 15.29 min, P<0.01).The recanalization rate was 70% in the study group and 65.38% in the control group (P<0.05). The incidence of cardiac events was 10% in the study group and 23.07% in the control group (P<0.05).Conclusions Prehospital thrombolytic therapy can shorten the interval from onset of AMI to thrombolytic treatment, enhancing the rate of myocardial reperfusion and reducing the incidence of cardiac events.It is a safe and necessary procudure.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号